Global Immunohematology Market Growth (Status and Outlook) 2026-2032
The global Immunohematology market size is predicted to grow from US$ 2506 million in 2025 to US$ 3377 million in 2032; it is expected to grow at a CAGR of 4.8% from 2026 to 2032.
Commercially, immunohematology usually refers to pre-transfusion compatibility testing and blood-group serology/molecular typing solutions. The core menu includes ABO/Rh typing, antibody screening, antibody identification, crossmatching, DAT/IAT, antigen typing/extended phenotyping, and selected molecular typing for rare or complex cases. Product formats span gel/cards, reagent red cells, antisera, QC materials, fully/semi-automated analyzers, data-management software, and in some cases reference-laboratory testing services. Upstream inputs include antibodies, reagent RBC materials, plastics/consumables, automation modules, and software; midstream is reagent?instrument system integration; downstream customers are primarily hospital transfusion laboratories/blood banks, independent labs, blood centers, and reference labs.
Immunohematology, as a core interdisciplinary field integrating immunology and hematology, focuses on the interaction between blood components and the immune system, covering key areas such as blood grouping, transfusion safety, diagnosis and treatment of autoimmune hematological diseases, and hematopoietic stem cell transplantation matching. It is an important part of the global healthcare system, and its development is closely linked to multiple global trends, including the upgrading of clinical needs, breakthroughs in technological innovation, and the protection of public health security. The continuous growth of global clinical transfusion demand and the continuous improvement of transfusion safety standards are the core driving forces. The demand for safe blood transfusion in various surgeries, chronic diseases and trauma treatment has promoted the transformation of immunohematology technology towards precision and standardization, reducing the risk of transfusion adverse reactions. The clinical diagnosis and treatment needs of hematological tumors, autoimmune hematological diseases and other diseases have promoted the discipline to extend towards precise immunotherapy and personalized diagnosis and treatment, broadening the research and application boundaries. Technological innovation continues to empower the industry. The application of automated detection platforms, molecular typing technologies, AI-assisted interpretation systems and other technologies has improved detection efficiency and accuracy, promoting the discipline to develop in a diversified and cross-integrated direction. The improvement of the global public health system and the enhancement of blood safety awareness have promoted countries to strengthen blood screening, rare blood type bank construction and standardized construction of immunohematology laboratories. At the same time, the upgrading of medical infrastructure in emerging markets has released new growth for the development of the discipline. The global cooperation between leading enterprises and scientific research institutions has accelerated the global popularization of technological achievements.
Despite the continuous development of the global immunohematology field and the increasing clinical value, it still faces many challenges. High-end technologies and core reagent barriers are strict. The core technologies of precise molecular typing, high-end detection equipment and key reagents are monopolized by a few international leading enterprises. Emerging markets and developing countries have insufficient investment in scientific research, making it difficult to achieve technological breakthroughs and independent substitution, resulting in unbalanced distribution of medical resources. There are regional differences in the development of the discipline. Developed countries, relying on mature medical systems and scientific research strength, focus on cutting-edge technology research and development and clinical application, occupying a dominant position in the industry. However, some developing countries, limited by medical resources and professional talents, have insufficient accessibility of immunohematology detection and diagnosis and treatment services. There is a gap between clinical application and technological transformation. Some cutting-edge technologies have high R&D costs and long certification cycles, making it difficult to quickly land and popularize. At the same time, the shortage of professional and technical talents restricts the promotion and application of disciplinary technologies. In addition, there are regional differences in global industry standards and regulatory norms. Different countries have different requirements for detection processes, reagent certification and quality control, increasing the difficulty of cross-border promotion of technologies and products. Coupled with the safety and ethical controversies of some technologies, the balanced and high-quality development of global immunohematology is further restricted.
LPI (LP Information)' newest research report, the ?Immunohematology Industry Forecast? looks at past sales and reviews total world Immunohematology sales in 2025, providing a comprehensive analysis by region and market sector of projected Immunohematology sales for 2026 through 2032. With Immunohematology sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Immunohematology industry.
This Insight Report provides a comprehensive analysis of the global Immunohematology landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Immunohematology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Immunohematology market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Immunohematology and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Immunohematology.
This report presents a comprehensive overview, market shares, and growth opportunities of Immunohematology market by product type, application, key players and key regions and countries.
Segmentation by Type:
Commercially, immunohematology usually refers to pre-transfusion compatibility testing and blood-group serology/molecular typing solutions. The core menu includes ABO/Rh typing, antibody screening, antibody identification, crossmatching, DAT/IAT, antigen typing/extended phenotyping, and selected molecular typing for rare or complex cases. Product formats span gel/cards, reagent red cells, antisera, QC materials, fully/semi-automated analyzers, data-management software, and in some cases reference-laboratory testing services. Upstream inputs include antibodies, reagent RBC materials, plastics/consumables, automation modules, and software; midstream is reagent?instrument system integration; downstream customers are primarily hospital transfusion laboratories/blood banks, independent labs, blood centers, and reference labs.
Immunohematology, as a core interdisciplinary field integrating immunology and hematology, focuses on the interaction between blood components and the immune system, covering key areas such as blood grouping, transfusion safety, diagnosis and treatment of autoimmune hematological diseases, and hematopoietic stem cell transplantation matching. It is an important part of the global healthcare system, and its development is closely linked to multiple global trends, including the upgrading of clinical needs, breakthroughs in technological innovation, and the protection of public health security. The continuous growth of global clinical transfusion demand and the continuous improvement of transfusion safety standards are the core driving forces. The demand for safe blood transfusion in various surgeries, chronic diseases and trauma treatment has promoted the transformation of immunohematology technology towards precision and standardization, reducing the risk of transfusion adverse reactions. The clinical diagnosis and treatment needs of hematological tumors, autoimmune hematological diseases and other diseases have promoted the discipline to extend towards precise immunotherapy and personalized diagnosis and treatment, broadening the research and application boundaries. Technological innovation continues to empower the industry. The application of automated detection platforms, molecular typing technologies, AI-assisted interpretation systems and other technologies has improved detection efficiency and accuracy, promoting the discipline to develop in a diversified and cross-integrated direction. The improvement of the global public health system and the enhancement of blood safety awareness have promoted countries to strengthen blood screening, rare blood type bank construction and standardized construction of immunohematology laboratories. At the same time, the upgrading of medical infrastructure in emerging markets has released new growth for the development of the discipline. The global cooperation between leading enterprises and scientific research institutions has accelerated the global popularization of technological achievements.
Despite the continuous development of the global immunohematology field and the increasing clinical value, it still faces many challenges. High-end technologies and core reagent barriers are strict. The core technologies of precise molecular typing, high-end detection equipment and key reagents are monopolized by a few international leading enterprises. Emerging markets and developing countries have insufficient investment in scientific research, making it difficult to achieve technological breakthroughs and independent substitution, resulting in unbalanced distribution of medical resources. There are regional differences in the development of the discipline. Developed countries, relying on mature medical systems and scientific research strength, focus on cutting-edge technology research and development and clinical application, occupying a dominant position in the industry. However, some developing countries, limited by medical resources and professional talents, have insufficient accessibility of immunohematology detection and diagnosis and treatment services. There is a gap between clinical application and technological transformation. Some cutting-edge technologies have high R&D costs and long certification cycles, making it difficult to quickly land and popularize. At the same time, the shortage of professional and technical talents restricts the promotion and application of disciplinary technologies. In addition, there are regional differences in global industry standards and regulatory norms. Different countries have different requirements for detection processes, reagent certification and quality control, increasing the difficulty of cross-border promotion of technologies and products. Coupled with the safety and ethical controversies of some technologies, the balanced and high-quality development of global immunohematology is further restricted.
LPI (LP Information)' newest research report, the ?Immunohematology Industry Forecast? looks at past sales and reviews total world Immunohematology sales in 2025, providing a comprehensive analysis by region and market sector of projected Immunohematology sales for 2026 through 2032. With Immunohematology sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Immunohematology industry.
This Insight Report provides a comprehensive analysis of the global Immunohematology landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Immunohematology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Immunohematology market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Immunohematology and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Immunohematology.
This report presents a comprehensive overview, market shares, and growth opportunities of Immunohematology market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Immunohematology Analyzers and Systems
- Immunohematology Reagent
- Hospital Transfusion Department/Blood Bank
- Blood Center/Blood Collection and Supply Institution
- Reference Laboratory/Transplant Center
- Others
- Conventional High Frequency
- High Complexity/High Added Value
- Blood-Related Diseases
- HIV
- Hepatitis
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bio-Rad Laboratories
- Grifols
- Immucor (Werfen)
- QuidelOrtho
- Beckman Coulter
- DIAGAST
- Hemo bioscience
- Institut de Biotechnologies Jacques Boy
- MTC INVITRO
- AliveDx
- AI KANG
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Immunohematology Market Size (2021-2032)
2.1.2 Immunohematology Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Immunohematology by Country/Region (2021, 2025 & 2032)
2.2 Immunohematology Segment by Type
2.2.1 Immunohematology Analyzers and Systems
2.2.2 Immunohematology Reagent
2.2.3 Immunohematology Market Size by Type
2.2.3.1 Immunohematology Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Immunohematology Market Size Market Share by Type (2021-2026)
2.3 Immunohematology Segment by Downstream Customers
2.3.1 Hospital Transfusion Department/Blood Bank
2.3.2 Blood Center/Blood Collection and Supply Institution
2.3.3 Reference Laboratory/Transplant Center
2.3.4 Others
2.3.5 Immunohematology Market Size by Downstream Customers
2.3.5.1 Immunohematology Market Size CAGR by Downstream Customers (2021 VS 2025 VS 2032)
2.3.5.2 Global Immunohematology Market Size Market Share by Downstream Customers (2021-2026)
2.4 Immunohematology Segment by Clinical Complexity
2.4.1 Conventional High Frequency
2.4.2 High Complexity/High Added Value
2.4.3 Immunohematology Market Size by Clinical Complexity
2.4.3.1 Immunohematology Market Size CAGR by Clinical Complexity (2021 VS 2025 VS 2032)
2.4.3.2 Global Immunohematology Market Size Market Share by Clinical Complexity (2021-2026)
2.5 Immunohematology Segment by Application
2.5.1 Blood-Related Diseases
2.5.2 HIV
2.5.3 Hepatitis
2.5.4 Immunohematology Market Size by Application
2.5.4.1 Immunohematology Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global Immunohematology Market Size Market Share by Application (2021-2026)
3 IMMUNOHEMATOLOGY MARKET SIZE BY PLAYER
3.1 Immunohematology Market Size Market Share by Player
3.1.1 Global Immunohematology Revenue by Player (2021-2026)
3.1.2 Global Immunohematology Revenue Market Share by Player (2021-2026)
3.2 Global Immunohematology Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 IMMUNOHEMATOLOGY BY REGION
4.1 Immunohematology Market Size by Region (2021-2026)
4.2 Global Immunohematology Annual Revenue by Country/Region (2021-2026)
4.3 Americas Immunohematology Market Size Growth (2021-2026)
4.4 APAC Immunohematology Market Size Growth (2021-2026)
4.5 Europe Immunohematology Market Size Growth (2021-2026)
4.6 Middle East & Africa Immunohematology Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Immunohematology Market Size by Country (2021-2026)
5.2 Americas Immunohematology Market Size by Type (2021-2026)
5.3 Americas Immunohematology Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Immunohematology Market Size by Region (2021-2026)
6.2 APAC Immunohematology Market Size by Type (2021-2026)
6.3 APAC Immunohematology Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Immunohematology Market Size by Country (2021-2026)
7.2 Europe Immunohematology Market Size by Type (2021-2026)
7.3 Europe Immunohematology Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Immunohematology by Region (2021-2026)
8.2 Middle East & Africa Immunohematology Market Size by Type (2021-2026)
8.3 Middle East & Africa Immunohematology Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL IMMUNOHEMATOLOGY MARKET FORECAST
10.1 Global Immunohematology Forecast by Region (2027-2032)
10.1.1 Global Immunohematology Forecast by Region (2027-2032)
10.1.2 Americas Immunohematology Forecast
10.1.3 APAC Immunohematology Forecast
10.1.4 Europe Immunohematology Forecast
10.1.5 Middle East & Africa Immunohematology Forecast
10.2 Americas Immunohematology Forecast by Country (2027-2032)
10.2.1 United States Market Immunohematology Forecast
10.2.2 Canada Market Immunohematology Forecast
10.2.3 Mexico Market Immunohematology Forecast
10.2.4 Brazil Market Immunohematology Forecast
10.3 APAC Immunohematology Forecast by Region (2027-2032)
10.3.1 China Immunohematology Market Forecast
10.3.2 Japan Market Immunohematology Forecast
10.3.3 Korea Market Immunohematology Forecast
10.3.4 Southeast Asia Market Immunohematology Forecast
10.3.5 India Market Immunohematology Forecast
10.3.6 Australia Market Immunohematology Forecast
10.4 Europe Immunohematology Forecast by Country (2027-2032)
10.4.1 Germany Market Immunohematology Forecast
10.4.2 France Market Immunohematology Forecast
10.4.3 UK Market Immunohematology Forecast
10.4.4 Italy Market Immunohematology Forecast
10.4.5 Russia Market Immunohematology Forecast
10.5 Middle East & Africa Immunohematology Forecast by Region (2027-2032)
10.5.1 Egypt Market Immunohematology Forecast
10.5.2 South Africa Market Immunohematology Forecast
10.5.3 Israel Market Immunohematology Forecast
10.5.4 Turkey Market Immunohematology Forecast
10.6 Global Immunohematology Forecast by Type (2027-2032)
10.7 Global Immunohematology Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Immunohematology Forecast
11 KEY PLAYERS ANALYSIS
11.1 Bio-Rad Laboratories
11.1.1 Bio-Rad Laboratories Company Information
11.1.2 Bio-Rad Laboratories Immunohematology Product Offered
11.1.3 Bio-Rad Laboratories Immunohematology Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Bio-Rad Laboratories Main Business Overview
11.1.5 Bio-Rad Laboratories Latest Developments
11.2 Grifols
11.2.1 Grifols Company Information
11.2.2 Grifols Immunohematology Product Offered
11.2.3 Grifols Immunohematology Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Grifols Main Business Overview
11.2.5 Grifols Latest Developments
11.3 Immucor (Werfen)
11.3.1 Immucor (Werfen) Company Information
11.3.2 Immucor (Werfen) Immunohematology Product Offered
11.3.3 Immucor (Werfen) Immunohematology Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Immucor (Werfen) Main Business Overview
11.3.5 Immucor (Werfen) Latest Developments
11.4 QuidelOrtho
11.4.1 QuidelOrtho Company Information
11.4.2 QuidelOrtho Immunohematology Product Offered
11.4.3 QuidelOrtho Immunohematology Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 QuidelOrtho Main Business Overview
11.4.5 QuidelOrtho Latest Developments
11.5 Beckman Coulter
11.5.1 Beckman Coulter Company Information
11.5.2 Beckman Coulter Immunohematology Product Offered
11.5.3 Beckman Coulter Immunohematology Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Beckman Coulter Main Business Overview
11.5.5 Beckman Coulter Latest Developments
11.6 DIAGAST
11.6.1 DIAGAST Company Information
11.6.2 DIAGAST Immunohematology Product Offered
11.6.3 DIAGAST Immunohematology Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 DIAGAST Main Business Overview
11.6.5 DIAGAST Latest Developments
11.7 Hemo bioscience
11.7.1 Hemo bioscience Company Information
11.7.2 Hemo bioscience Immunohematology Product Offered
11.7.3 Hemo bioscience Immunohematology Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Hemo bioscience Main Business Overview
11.7.5 Hemo bioscience Latest Developments
11.8 Institut de Biotechnologies Jacques Boy
11.8.1 Institut de Biotechnologies Jacques Boy Company Information
11.8.2 Institut de Biotechnologies Jacques Boy Immunohematology Product Offered
11.8.3 Institut de Biotechnologies Jacques Boy Immunohematology Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Institut de Biotechnologies Jacques Boy Main Business Overview
11.8.5 Institut de Biotechnologies Jacques Boy Latest Developments
11.9 MTC INVITRO
11.9.1 MTC INVITRO Company Information
11.9.2 MTC INVITRO Immunohematology Product Offered
11.9.3 MTC INVITRO Immunohematology Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 MTC INVITRO Main Business Overview
11.9.5 MTC INVITRO Latest Developments
11.10 AliveDx
11.10.1 AliveDx Company Information
11.10.2 AliveDx Immunohematology Product Offered
11.10.3 AliveDx Immunohematology Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 AliveDx Main Business Overview
11.10.5 AliveDx Latest Developments
11.11 AI KANG
11.11.1 AI KANG Company Information
11.11.2 AI KANG Immunohematology Product Offered
11.11.3 AI KANG Immunohematology Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 AI KANG Main Business Overview
11.11.5 AI KANG Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Immunohematology Market Size (2021-2032)
2.1.2 Immunohematology Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Immunohematology by Country/Region (2021, 2025 & 2032)
2.2 Immunohematology Segment by Type
2.2.1 Immunohematology Analyzers and Systems
2.2.2 Immunohematology Reagent
2.2.3 Immunohematology Market Size by Type
2.2.3.1 Immunohematology Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Immunohematology Market Size Market Share by Type (2021-2026)
2.3 Immunohematology Segment by Downstream Customers
2.3.1 Hospital Transfusion Department/Blood Bank
2.3.2 Blood Center/Blood Collection and Supply Institution
2.3.3 Reference Laboratory/Transplant Center
2.3.4 Others
2.3.5 Immunohematology Market Size by Downstream Customers
2.3.5.1 Immunohematology Market Size CAGR by Downstream Customers (2021 VS 2025 VS 2032)
2.3.5.2 Global Immunohematology Market Size Market Share by Downstream Customers (2021-2026)
2.4 Immunohematology Segment by Clinical Complexity
2.4.1 Conventional High Frequency
2.4.2 High Complexity/High Added Value
2.4.3 Immunohematology Market Size by Clinical Complexity
2.4.3.1 Immunohematology Market Size CAGR by Clinical Complexity (2021 VS 2025 VS 2032)
2.4.3.2 Global Immunohematology Market Size Market Share by Clinical Complexity (2021-2026)
2.5 Immunohematology Segment by Application
2.5.1 Blood-Related Diseases
2.5.2 HIV
2.5.3 Hepatitis
2.5.4 Immunohematology Market Size by Application
2.5.4.1 Immunohematology Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global Immunohematology Market Size Market Share by Application (2021-2026)
3 IMMUNOHEMATOLOGY MARKET SIZE BY PLAYER
3.1 Immunohematology Market Size Market Share by Player
3.1.1 Global Immunohematology Revenue by Player (2021-2026)
3.1.2 Global Immunohematology Revenue Market Share by Player (2021-2026)
3.2 Global Immunohematology Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 IMMUNOHEMATOLOGY BY REGION
4.1 Immunohematology Market Size by Region (2021-2026)
4.2 Global Immunohematology Annual Revenue by Country/Region (2021-2026)
4.3 Americas Immunohematology Market Size Growth (2021-2026)
4.4 APAC Immunohematology Market Size Growth (2021-2026)
4.5 Europe Immunohematology Market Size Growth (2021-2026)
4.6 Middle East & Africa Immunohematology Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Immunohematology Market Size by Country (2021-2026)
5.2 Americas Immunohematology Market Size by Type (2021-2026)
5.3 Americas Immunohematology Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Immunohematology Market Size by Region (2021-2026)
6.2 APAC Immunohematology Market Size by Type (2021-2026)
6.3 APAC Immunohematology Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Immunohematology Market Size by Country (2021-2026)
7.2 Europe Immunohematology Market Size by Type (2021-2026)
7.3 Europe Immunohematology Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Immunohematology by Region (2021-2026)
8.2 Middle East & Africa Immunohematology Market Size by Type (2021-2026)
8.3 Middle East & Africa Immunohematology Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL IMMUNOHEMATOLOGY MARKET FORECAST
10.1 Global Immunohematology Forecast by Region (2027-2032)
10.1.1 Global Immunohematology Forecast by Region (2027-2032)
10.1.2 Americas Immunohematology Forecast
10.1.3 APAC Immunohematology Forecast
10.1.4 Europe Immunohematology Forecast
10.1.5 Middle East & Africa Immunohematology Forecast
10.2 Americas Immunohematology Forecast by Country (2027-2032)
10.2.1 United States Market Immunohematology Forecast
10.2.2 Canada Market Immunohematology Forecast
10.2.3 Mexico Market Immunohematology Forecast
10.2.4 Brazil Market Immunohematology Forecast
10.3 APAC Immunohematology Forecast by Region (2027-2032)
10.3.1 China Immunohematology Market Forecast
10.3.2 Japan Market Immunohematology Forecast
10.3.3 Korea Market Immunohematology Forecast
10.3.4 Southeast Asia Market Immunohematology Forecast
10.3.5 India Market Immunohematology Forecast
10.3.6 Australia Market Immunohematology Forecast
10.4 Europe Immunohematology Forecast by Country (2027-2032)
10.4.1 Germany Market Immunohematology Forecast
10.4.2 France Market Immunohematology Forecast
10.4.3 UK Market Immunohematology Forecast
10.4.4 Italy Market Immunohematology Forecast
10.4.5 Russia Market Immunohematology Forecast
10.5 Middle East & Africa Immunohematology Forecast by Region (2027-2032)
10.5.1 Egypt Market Immunohematology Forecast
10.5.2 South Africa Market Immunohematology Forecast
10.5.3 Israel Market Immunohematology Forecast
10.5.4 Turkey Market Immunohematology Forecast
10.6 Global Immunohematology Forecast by Type (2027-2032)
10.7 Global Immunohematology Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Immunohematology Forecast
11 KEY PLAYERS ANALYSIS
11.1 Bio-Rad Laboratories
11.1.1 Bio-Rad Laboratories Company Information
11.1.2 Bio-Rad Laboratories Immunohematology Product Offered
11.1.3 Bio-Rad Laboratories Immunohematology Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Bio-Rad Laboratories Main Business Overview
11.1.5 Bio-Rad Laboratories Latest Developments
11.2 Grifols
11.2.1 Grifols Company Information
11.2.2 Grifols Immunohematology Product Offered
11.2.3 Grifols Immunohematology Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Grifols Main Business Overview
11.2.5 Grifols Latest Developments
11.3 Immucor (Werfen)
11.3.1 Immucor (Werfen) Company Information
11.3.2 Immucor (Werfen) Immunohematology Product Offered
11.3.3 Immucor (Werfen) Immunohematology Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Immucor (Werfen) Main Business Overview
11.3.5 Immucor (Werfen) Latest Developments
11.4 QuidelOrtho
11.4.1 QuidelOrtho Company Information
11.4.2 QuidelOrtho Immunohematology Product Offered
11.4.3 QuidelOrtho Immunohematology Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 QuidelOrtho Main Business Overview
11.4.5 QuidelOrtho Latest Developments
11.5 Beckman Coulter
11.5.1 Beckman Coulter Company Information
11.5.2 Beckman Coulter Immunohematology Product Offered
11.5.3 Beckman Coulter Immunohematology Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Beckman Coulter Main Business Overview
11.5.5 Beckman Coulter Latest Developments
11.6 DIAGAST
11.6.1 DIAGAST Company Information
11.6.2 DIAGAST Immunohematology Product Offered
11.6.3 DIAGAST Immunohematology Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 DIAGAST Main Business Overview
11.6.5 DIAGAST Latest Developments
11.7 Hemo bioscience
11.7.1 Hemo bioscience Company Information
11.7.2 Hemo bioscience Immunohematology Product Offered
11.7.3 Hemo bioscience Immunohematology Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Hemo bioscience Main Business Overview
11.7.5 Hemo bioscience Latest Developments
11.8 Institut de Biotechnologies Jacques Boy
11.8.1 Institut de Biotechnologies Jacques Boy Company Information
11.8.2 Institut de Biotechnologies Jacques Boy Immunohematology Product Offered
11.8.3 Institut de Biotechnologies Jacques Boy Immunohematology Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Institut de Biotechnologies Jacques Boy Main Business Overview
11.8.5 Institut de Biotechnologies Jacques Boy Latest Developments
11.9 MTC INVITRO
11.9.1 MTC INVITRO Company Information
11.9.2 MTC INVITRO Immunohematology Product Offered
11.9.3 MTC INVITRO Immunohematology Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 MTC INVITRO Main Business Overview
11.9.5 MTC INVITRO Latest Developments
11.10 AliveDx
11.10.1 AliveDx Company Information
11.10.2 AliveDx Immunohematology Product Offered
11.10.3 AliveDx Immunohematology Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 AliveDx Main Business Overview
11.10.5 AliveDx Latest Developments
11.11 AI KANG
11.11.1 AI KANG Company Information
11.11.2 AI KANG Immunohematology Product Offered
11.11.3 AI KANG Immunohematology Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 AI KANG Main Business Overview
11.11.5 AI KANG Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Immunohematology Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Immunohematology Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Immunohematology Analyzers and Systems
Table 4. Major Players of Immunohematology Reagent
Table 5. Immunohematology Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Immunohematology Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Immunohematology Market Size Market Share by Type (2021-2026)
Table 8. Major Players of Hospital Transfusion Department/Blood Bank
Table 9. Major Players of Blood Center/Blood Collection and Supply Institution
Table 10. Major Players of Reference Laboratory/Transplant Center
Table 11. Major Players of Others
Table 12. Immunohematology Market Size CAGR by Downstream Customers (2021 VS 2025 VS 2032) & ($ millions)
Table 13. Global Immunohematology Market Size by Downstream Customers (2021-2026) & ($ millions)
Table 14. Global Immunohematology Market Size Market Share by Downstream Customers (2021-2026)
Table 15. Major Players of Conventional High Frequency
Table 16. Major Players of High Complexity/High Added Value
Table 17. Immunohematology Market Size CAGR by Clinical Complexity (2021 VS 2025 VS 2032) & ($ millions)
Table 18. Global Immunohematology Market Size by Clinical Complexity (2021-2026) & ($ millions)
Table 19. Global Immunohematology Market Size Market Share by Clinical Complexity (2021-2026)
Table 20. Immunohematology Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 21. Global Immunohematology Market Size by Application (2021-2026) & ($ millions)
Table 22. Global Immunohematology Market Size Market Share by Application (2021-2026)
Table 23. Global Immunohematology Revenue by Player (2021-2026) & ($ millions)
Table 24. Global Immunohematology Revenue Market Share by Player (2021-2026)
Table 25. Immunohematology Key Players Head office and Products Offered
Table 26. Immunohematology Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Immunohematology Market Size by Region (2021-2026) & ($ millions)
Table 30. Global Immunohematology Market Size Market Share by Region (2021-2026)
Table 31. Global Immunohematology Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Immunohematology Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Immunohematology Market Size by Country (2021-2026) & ($ millions)
Table 34. Americas Immunohematology Market Size Market Share by Country (2021-2026)
Table 35. Americas Immunohematology Market Size by Type (2021-2026) & ($ millions)
Table 36. Americas Immunohematology Market Size Market Share by Type (2021-2026)
Table 37. Americas Immunohematology Market Size by Application (2021-2026) & ($ millions)
Table 38. Americas Immunohematology Market Size Market Share by Application (2021-2026)
Table 39. APAC Immunohematology Market Size by Region (2021-2026) & ($ millions)
Table 40. APAC Immunohematology Market Size Market Share by Region (2021-2026)
Table 41. APAC Immunohematology Market Size by Type (2021-2026) & ($ millions)
Table 42. APAC Immunohematology Market Size by Application (2021-2026) & ($ millions)
Table 43. Europe Immunohematology Market Size by Country (2021-2026) & ($ millions)
Table 44. Europe Immunohematology Market Size Market Share by Country (2021-2026)
Table 45. Europe Immunohematology Market Size by Type (2021-2026) & ($ millions)
Table 46. Europe Immunohematology Market Size by Application (2021-2026) & ($ millions)
Table 47. Middle East & Africa Immunohematology Market Size by Region (2021-2026) & ($ millions)
Table 48. Middle East & Africa Immunohematology Market Size by Type (2021-2026) & ($ millions)
Table 49. Middle East & Africa Immunohematology Market Size by Application (2021-2026) & ($ millions)
Table 50. Key Market Drivers & Growth Opportunities of Immunohematology
Table 51. Key Market Challenges & Risks of Immunohematology
Table 52. Key Industry Trends of Immunohematology
Table 53. Global Immunohematology Market Size Forecast by Region (2027-2032) & ($ millions)
Table 54. Global Immunohematology Market Size Market Share Forecast by Region (2027-2032)
Table 55. Global Immunohematology Market Size Forecast by Type (2027-2032) & ($ millions)
Table 56. Global Immunohematology Market Size Forecast by Application (2027-2032) & ($ millions)
Table 57. Bio-Rad Laboratories Details, Company Type, Immunohematology Area Served and Its Competitors
Table 58. Bio-Rad Laboratories Immunohematology Product Offered
Table 59. Bio-Rad Laboratories Immunohematology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Bio-Rad Laboratories Main Business
Table 61. Bio-Rad Laboratories Latest Developments
Table 62. Grifols Details, Company Type, Immunohematology Area Served and Its Competitors
Table 63. Grifols Immunohematology Product Offered
Table 64. Grifols Immunohematology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. Grifols Main Business
Table 66. Grifols Latest Developments
Table 67. Immucor (Werfen) Details, Company Type, Immunohematology Area Served and Its Competitors
Table 68. Immucor (Werfen) Immunohematology Product Offered
Table 69. Immucor (Werfen) Immunohematology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Immucor (Werfen) Main Business
Table 71. Immucor (Werfen) Latest Developments
Table 72. QuidelOrtho Details, Company Type, Immunohematology Area Served and Its Competitors
Table 73. QuidelOrtho Immunohematology Product Offered
Table 74. QuidelOrtho Immunohematology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. QuidelOrtho Main Business
Table 76. QuidelOrtho Latest Developments
Table 77. Beckman Coulter Details, Company Type, Immunohematology Area Served and Its Competitors
Table 78. Beckman Coulter Immunohematology Product Offered
Table 79. Beckman Coulter Immunohematology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. Beckman Coulter Main Business
Table 81. Beckman Coulter Latest Developments
Table 82. DIAGAST Details, Company Type, Immunohematology Area Served and Its Competitors
Table 83. DIAGAST Immunohematology Product Offered
Table 84. DIAGAST Immunohematology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. DIAGAST Main Business
Table 86. DIAGAST Latest Developments
Table 87. Hemo bioscience Details, Company Type, Immunohematology Area Served and Its Competitors
Table 88. Hemo bioscience Immunohematology Product Offered
Table 89. Hemo bioscience Immunohematology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. Hemo bioscience Main Business
Table 91. Hemo bioscience Latest Developments
Table 92. Institut de Biotechnologies Jacques Boy Details, Company Type, Immunohematology Area Served and Its Competitors
Table 93. Institut de Biotechnologies Jacques Boy Immunohematology Product Offered
Table 94. Institut de Biotechnologies Jacques Boy Immunohematology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. Institut de Biotechnologies Jacques Boy Main Business
Table 96. Institut de Biotechnologies Jacques Boy Latest Developments
Table 97. MTC INVITRO Details, Company Type, Immunohematology Area Served and Its Competitors
Table 98. MTC INVITRO Immunohematology Product Offered
Table 99. MTC INVITRO Immunohematology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. MTC INVITRO Main Business
Table 101. MTC INVITRO Latest Developments
Table 102. AliveDx Details, Company Type, Immunohematology Area Served and Its Competitors
Table 103. AliveDx Immunohematology Product Offered
Table 104. AliveDx Immunohematology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 105. AliveDx Main Business
Table 106. AliveDx Latest Developments
Table 107. AI KANG Details, Company Type, Immunohematology Area Served and Its Competitors
Table 108. AI KANG Immunohematology Product Offered
Table 109. AI KANG Immunohematology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 110. AI KANG Main Business
Table 111. AI KANG Latest Developments
Table 1. Immunohematology Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Immunohematology Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Immunohematology Analyzers and Systems
Table 4. Major Players of Immunohematology Reagent
Table 5. Immunohematology Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Immunohematology Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Immunohematology Market Size Market Share by Type (2021-2026)
Table 8. Major Players of Hospital Transfusion Department/Blood Bank
Table 9. Major Players of Blood Center/Blood Collection and Supply Institution
Table 10. Major Players of Reference Laboratory/Transplant Center
Table 11. Major Players of Others
Table 12. Immunohematology Market Size CAGR by Downstream Customers (2021 VS 2025 VS 2032) & ($ millions)
Table 13. Global Immunohematology Market Size by Downstream Customers (2021-2026) & ($ millions)
Table 14. Global Immunohematology Market Size Market Share by Downstream Customers (2021-2026)
Table 15. Major Players of Conventional High Frequency
Table 16. Major Players of High Complexity/High Added Value
Table 17. Immunohematology Market Size CAGR by Clinical Complexity (2021 VS 2025 VS 2032) & ($ millions)
Table 18. Global Immunohematology Market Size by Clinical Complexity (2021-2026) & ($ millions)
Table 19. Global Immunohematology Market Size Market Share by Clinical Complexity (2021-2026)
Table 20. Immunohematology Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 21. Global Immunohematology Market Size by Application (2021-2026) & ($ millions)
Table 22. Global Immunohematology Market Size Market Share by Application (2021-2026)
Table 23. Global Immunohematology Revenue by Player (2021-2026) & ($ millions)
Table 24. Global Immunohematology Revenue Market Share by Player (2021-2026)
Table 25. Immunohematology Key Players Head office and Products Offered
Table 26. Immunohematology Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Immunohematology Market Size by Region (2021-2026) & ($ millions)
Table 30. Global Immunohematology Market Size Market Share by Region (2021-2026)
Table 31. Global Immunohematology Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Immunohematology Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Immunohematology Market Size by Country (2021-2026) & ($ millions)
Table 34. Americas Immunohematology Market Size Market Share by Country (2021-2026)
Table 35. Americas Immunohematology Market Size by Type (2021-2026) & ($ millions)
Table 36. Americas Immunohematology Market Size Market Share by Type (2021-2026)
Table 37. Americas Immunohematology Market Size by Application (2021-2026) & ($ millions)
Table 38. Americas Immunohematology Market Size Market Share by Application (2021-2026)
Table 39. APAC Immunohematology Market Size by Region (2021-2026) & ($ millions)
Table 40. APAC Immunohematology Market Size Market Share by Region (2021-2026)
Table 41. APAC Immunohematology Market Size by Type (2021-2026) & ($ millions)
Table 42. APAC Immunohematology Market Size by Application (2021-2026) & ($ millions)
Table 43. Europe Immunohematology Market Size by Country (2021-2026) & ($ millions)
Table 44. Europe Immunohematology Market Size Market Share by Country (2021-2026)
Table 45. Europe Immunohematology Market Size by Type (2021-2026) & ($ millions)
Table 46. Europe Immunohematology Market Size by Application (2021-2026) & ($ millions)
Table 47. Middle East & Africa Immunohematology Market Size by Region (2021-2026) & ($ millions)
Table 48. Middle East & Africa Immunohematology Market Size by Type (2021-2026) & ($ millions)
Table 49. Middle East & Africa Immunohematology Market Size by Application (2021-2026) & ($ millions)
Table 50. Key Market Drivers & Growth Opportunities of Immunohematology
Table 51. Key Market Challenges & Risks of Immunohematology
Table 52. Key Industry Trends of Immunohematology
Table 53. Global Immunohematology Market Size Forecast by Region (2027-2032) & ($ millions)
Table 54. Global Immunohematology Market Size Market Share Forecast by Region (2027-2032)
Table 55. Global Immunohematology Market Size Forecast by Type (2027-2032) & ($ millions)
Table 56. Global Immunohematology Market Size Forecast by Application (2027-2032) & ($ millions)
Table 57. Bio-Rad Laboratories Details, Company Type, Immunohematology Area Served and Its Competitors
Table 58. Bio-Rad Laboratories Immunohematology Product Offered
Table 59. Bio-Rad Laboratories Immunohematology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Bio-Rad Laboratories Main Business
Table 61. Bio-Rad Laboratories Latest Developments
Table 62. Grifols Details, Company Type, Immunohematology Area Served and Its Competitors
Table 63. Grifols Immunohematology Product Offered
Table 64. Grifols Immunohematology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. Grifols Main Business
Table 66. Grifols Latest Developments
Table 67. Immucor (Werfen) Details, Company Type, Immunohematology Area Served and Its Competitors
Table 68. Immucor (Werfen) Immunohematology Product Offered
Table 69. Immucor (Werfen) Immunohematology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Immucor (Werfen) Main Business
Table 71. Immucor (Werfen) Latest Developments
Table 72. QuidelOrtho Details, Company Type, Immunohematology Area Served and Its Competitors
Table 73. QuidelOrtho Immunohematology Product Offered
Table 74. QuidelOrtho Immunohematology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. QuidelOrtho Main Business
Table 76. QuidelOrtho Latest Developments
Table 77. Beckman Coulter Details, Company Type, Immunohematology Area Served and Its Competitors
Table 78. Beckman Coulter Immunohematology Product Offered
Table 79. Beckman Coulter Immunohematology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. Beckman Coulter Main Business
Table 81. Beckman Coulter Latest Developments
Table 82. DIAGAST Details, Company Type, Immunohematology Area Served and Its Competitors
Table 83. DIAGAST Immunohematology Product Offered
Table 84. DIAGAST Immunohematology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. DIAGAST Main Business
Table 86. DIAGAST Latest Developments
Table 87. Hemo bioscience Details, Company Type, Immunohematology Area Served and Its Competitors
Table 88. Hemo bioscience Immunohematology Product Offered
Table 89. Hemo bioscience Immunohematology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. Hemo bioscience Main Business
Table 91. Hemo bioscience Latest Developments
Table 92. Institut de Biotechnologies Jacques Boy Details, Company Type, Immunohematology Area Served and Its Competitors
Table 93. Institut de Biotechnologies Jacques Boy Immunohematology Product Offered
Table 94. Institut de Biotechnologies Jacques Boy Immunohematology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. Institut de Biotechnologies Jacques Boy Main Business
Table 96. Institut de Biotechnologies Jacques Boy Latest Developments
Table 97. MTC INVITRO Details, Company Type, Immunohematology Area Served and Its Competitors
Table 98. MTC INVITRO Immunohematology Product Offered
Table 99. MTC INVITRO Immunohematology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. MTC INVITRO Main Business
Table 101. MTC INVITRO Latest Developments
Table 102. AliveDx Details, Company Type, Immunohematology Area Served and Its Competitors
Table 103. AliveDx Immunohematology Product Offered
Table 104. AliveDx Immunohematology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 105. AliveDx Main Business
Table 106. AliveDx Latest Developments
Table 107. AI KANG Details, Company Type, Immunohematology Area Served and Its Competitors
Table 108. AI KANG Immunohematology Product Offered
Table 109. AI KANG Immunohematology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 110. AI KANG Main Business
Table 111. AI KANG Latest Developments
LIST OF FIGURES
Figure 1. Immunohematology Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Immunohematology Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Immunohematology Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Immunohematology Sales Market Share by Country/Region (2025)
Figure 8. Immunohematology Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Immunohematology Market Size Market Share by Type in 2025
Figure 10. Global Immunohematology Market Size Market Share by Downstream Customers in 2025
Figure 11. Global Immunohematology Market Size Market Share by Clinical Complexity in 2025
Figure 12. Immunohematology in Blood-Related Diseases
Figure 13. Global Immunohematology Market: Blood-Related Diseases (2021-2026) & ($ millions)
Figure 14. Immunohematology in HIV
Figure 15. Global Immunohematology Market: HIV (2021-2026) & ($ millions)
Figure 16. Immunohematology in Hepatitis
Figure 17. Global Immunohematology Market: Hepatitis (2021-2026) & ($ millions)
Figure 18. Global Immunohematology Market Size Market Share by Application in 2025
Figure 19. Global Immunohematology Revenue Market Share by Player in 2025
Figure 20. Global Immunohematology Market Size Market Share by Region (2021-2026)
Figure 21. Americas Immunohematology Market Size 2021-2026 ($ millions)
Figure 22. APAC Immunohematology Market Size 2021-2026 ($ millions)
Figure 23. Europe Immunohematology Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Immunohematology Market Size 2021-2026 ($ millions)
Figure 25. Americas Immunohematology Value Market Share by Country in 2025
Figure 26. United States Immunohematology Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Immunohematology Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Immunohematology Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Immunohematology Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Immunohematology Market Size Market Share by Region in 2025
Figure 31. APAC Immunohematology Market Size Market Share by Type (2021-2026)
Figure 32. APAC Immunohematology Market Size Market Share by Application (2021-2026)
Figure 33. China Immunohematology Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Immunohematology Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Immunohematology Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Immunohematology Market Size Growth 2021-2026 ($ millions)
Figure 37. India Immunohematology Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Immunohematology Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Immunohematology Market Size Market Share by Country in 2025
Figure 40. Europe Immunohematology Market Size Market Share by Type (2021-2026)
Figure 41. Europe Immunohematology Market Size Market Share by Application (2021-2026)
Figure 42. Germany Immunohematology Market Size Growth 2021-2026 ($ millions)
Figure 43. France Immunohematology Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Immunohematology Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Immunohematology Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Immunohematology Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Immunohematology Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Immunohematology Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Immunohematology Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Immunohematology Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Immunohematology Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Immunohematology Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Immunohematology Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Immunohematology Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Immunohematology Market Size 2027-2032 ($ millions)
Figure 56. APAC Immunohematology Market Size 2027-2032 ($ millions)
Figure 57. Europe Immunohematology Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Immunohematology Market Size 2027-2032 ($ millions)
Figure 59. United States Immunohematology Market Size 2027-2032 ($ millions)
Figure 60. Canada Immunohematology Market Size 2027-2032 ($ millions)
Figure 61. Mexico Immunohematology Market Size 2027-2032 ($ millions)
Figure 62. Brazil Immunohematology Market Size 2027-2032 ($ millions)
Figure 63. China Immunohematology Market Size 2027-2032 ($ millions)
Figure 64. Japan Immunohematology Market Size 2027-2032 ($ millions)
Figure 65. Korea Immunohematology Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Immunohematology Market Size 2027-2032 ($ millions)
Figure 67. India Immunohematology Market Size 2027-2032 ($ millions)
Figure 68. Australia Immunohematology Market Size 2027-2032 ($ millions)
Figure 69. Germany Immunohematology Market Size 2027-2032 ($ millions)
Figure 70. France Immunohematology Market Size 2027-2032 ($ millions)
Figure 71. UK Immunohematology Market Size 2027-2032 ($ millions)
Figure 72. Italy Immunohematology Market Size 2027-2032 ($ millions)
Figure 73. Russia Immunohematology Market Size 2027-2032 ($ millions)
Figure 74. Egypt Immunohematology Market Size 2027-2032 ($ millions)
Figure 75. South Africa Immunohematology Market Size 2027-2032 ($ millions)
Figure 76. Israel Immunohematology Market Size 2027-2032 ($ millions)
Figure 77. Turkey Immunohematology Market Size 2027-2032 ($ millions)
Figure 78. Global Immunohematology Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Immunohematology Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Immunohematology Market Size 2027-2032 ($ millions)
Figure 1. Immunohematology Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Immunohematology Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Immunohematology Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Immunohematology Sales Market Share by Country/Region (2025)
Figure 8. Immunohematology Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Immunohematology Market Size Market Share by Type in 2025
Figure 10. Global Immunohematology Market Size Market Share by Downstream Customers in 2025
Figure 11. Global Immunohematology Market Size Market Share by Clinical Complexity in 2025
Figure 12. Immunohematology in Blood-Related Diseases
Figure 13. Global Immunohematology Market: Blood-Related Diseases (2021-2026) & ($ millions)
Figure 14. Immunohematology in HIV
Figure 15. Global Immunohematology Market: HIV (2021-2026) & ($ millions)
Figure 16. Immunohematology in Hepatitis
Figure 17. Global Immunohematology Market: Hepatitis (2021-2026) & ($ millions)
Figure 18. Global Immunohematology Market Size Market Share by Application in 2025
Figure 19. Global Immunohematology Revenue Market Share by Player in 2025
Figure 20. Global Immunohematology Market Size Market Share by Region (2021-2026)
Figure 21. Americas Immunohematology Market Size 2021-2026 ($ millions)
Figure 22. APAC Immunohematology Market Size 2021-2026 ($ millions)
Figure 23. Europe Immunohematology Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Immunohematology Market Size 2021-2026 ($ millions)
Figure 25. Americas Immunohematology Value Market Share by Country in 2025
Figure 26. United States Immunohematology Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Immunohematology Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Immunohematology Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Immunohematology Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Immunohematology Market Size Market Share by Region in 2025
Figure 31. APAC Immunohematology Market Size Market Share by Type (2021-2026)
Figure 32. APAC Immunohematology Market Size Market Share by Application (2021-2026)
Figure 33. China Immunohematology Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Immunohematology Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Immunohematology Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Immunohematology Market Size Growth 2021-2026 ($ millions)
Figure 37. India Immunohematology Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Immunohematology Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Immunohematology Market Size Market Share by Country in 2025
Figure 40. Europe Immunohematology Market Size Market Share by Type (2021-2026)
Figure 41. Europe Immunohematology Market Size Market Share by Application (2021-2026)
Figure 42. Germany Immunohematology Market Size Growth 2021-2026 ($ millions)
Figure 43. France Immunohematology Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Immunohematology Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Immunohematology Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Immunohematology Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Immunohematology Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Immunohematology Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Immunohematology Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Immunohematology Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Immunohematology Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Immunohematology Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Immunohematology Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Immunohematology Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Immunohematology Market Size 2027-2032 ($ millions)
Figure 56. APAC Immunohematology Market Size 2027-2032 ($ millions)
Figure 57. Europe Immunohematology Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Immunohematology Market Size 2027-2032 ($ millions)
Figure 59. United States Immunohematology Market Size 2027-2032 ($ millions)
Figure 60. Canada Immunohematology Market Size 2027-2032 ($ millions)
Figure 61. Mexico Immunohematology Market Size 2027-2032 ($ millions)
Figure 62. Brazil Immunohematology Market Size 2027-2032 ($ millions)
Figure 63. China Immunohematology Market Size 2027-2032 ($ millions)
Figure 64. Japan Immunohematology Market Size 2027-2032 ($ millions)
Figure 65. Korea Immunohematology Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Immunohematology Market Size 2027-2032 ($ millions)
Figure 67. India Immunohematology Market Size 2027-2032 ($ millions)
Figure 68. Australia Immunohematology Market Size 2027-2032 ($ millions)
Figure 69. Germany Immunohematology Market Size 2027-2032 ($ millions)
Figure 70. France Immunohematology Market Size 2027-2032 ($ millions)
Figure 71. UK Immunohematology Market Size 2027-2032 ($ millions)
Figure 72. Italy Immunohematology Market Size 2027-2032 ($ millions)
Figure 73. Russia Immunohematology Market Size 2027-2032 ($ millions)
Figure 74. Egypt Immunohematology Market Size 2027-2032 ($ millions)
Figure 75. South Africa Immunohematology Market Size 2027-2032 ($ millions)
Figure 76. Israel Immunohematology Market Size 2027-2032 ($ millions)
Figure 77. Turkey Immunohematology Market Size 2027-2032 ($ millions)
Figure 78. Global Immunohematology Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Immunohematology Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Immunohematology Market Size 2027-2032 ($ millions)
